|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 271.63 USD | +1.72% |
|
+5.16% | +12.77% |
| 06/02 | Resmed Insider Sold Shares Worth $502,620, According to a Recent SEC Filing | MT |
| 06/02 | ResMed Chief Legal Officer Sells 50 Common Shares Of Firm | MT |
Company Valuation: ResMed, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 35,903 | 30,691 | 32,133 | 28,117 | 37,762 | 39,571 | - | - |
| Change | - | -14.52% | 4.7% | -12.5% | 34.31% | 4.79% | - | - |
| Enterprise Value (EV) 1 | 36,263 | 31,192 | 33,346 | 28,585 | 37,221 | 38,505 | 37,698 | 36,652 |
| Change | - | -13.98% | 6.9% | -14.28% | 30.21% | 3.45% | -2.1% | -2.77% |
| P/E ratio | 76.1x | 39.6x | 35.9x | 27.7x | 27.1x | 25.7x | 23x | 21x |
| PBR | 12.4x | 9.35x | 7.76x | 5.78x | 6.33x | 5.8x | 5.09x | 4.72x |
| PEG | - | 0.6x | 2.4x | 2x | 0.7x | 2.3x | 2x | 2.25x |
| Capitalization / Revenue | 11.2x | 8.58x | 7.61x | 6x | 7.34x | 7.01x | 6.52x | 6.09x |
| EV / Revenue | 11.3x | 8.72x | 7.9x | 6.1x | 7.23x | 6.82x | 6.21x | 5.64x |
| EV / EBITDA | 33.8x | 26.8x | 25.3x | 18.1x | 19.8x | 17.5x | 15.9x | 14.2x |
| EV / EBIT | 40.1x | 31.2x | 27.2x | 19.3x | 21.1x | 18.8x | 16.8x | 15.1x |
| EV / FCF | 57.2x | 144x | 58.1x | 22x | 22.4x | 25.3x | 22.5x | 20.4x |
| FCF Yield | 1.75% | 0.69% | 1.72% | 4.55% | 4.46% | 3.95% | 4.44% | 4.91% |
| Dividend per Share 2 | 1.56 | 1.68 | 1.8 | 1.92 | 2.12 | 2.434 | 2.696 | 2.635 |
| Rate of return | 0.63% | 0.8% | 0.82% | 1% | 0.82% | 0.9% | 0.99% | 0.97% |
| EPS 2 | 3.24 | 5.3 | 6.09 | 6.92 | 9.51 | 10.59 | 11.81 | 12.92 |
| Distribution rate | 48.1% | 31.7% | 29.6% | 27.7% | 22.3% | 23% | 22.8% | 20.4% |
| Net sales 1 | 3,197 | 3,578 | 4,223 | 4,685 | 5,146 | 5,645 | 6,069 | 6,494 |
| EBITDA 1 | 1,074 | 1,162 | 1,317 | 1,576 | 1,884 | 2,198 | 2,368 | 2,576 |
| EBIT 1 | 903.7 | 1,000 | 1,224 | 1,478 | 1,763 | 2,050 | 2,239 | 2,422 |
| Net income 1 | 474.5 | 779.4 | 897.6 | 1,021 | 1,401 | 1,547 | 1,726 | 1,885 |
| Net Debt 1 | 360.1 | 501.5 | 1,213 | 468.9 | -541.2 | -1,066 | -1,873 | -2,918 |
| Reference price 2 | 246.52 | 209.63 | 218.50 | 191.42 | 258.00 | 271.63 | 271.63 | 271.63 |
| Nbr of stocks (in thousands) | 1,45,640 | 1,46,405 | 1,47,062 | 1,46,884 | 1,46,365 | 1,45,678 | - | - |
| Announcement Date | 05/08/21 | 11/08/22 | 03/08/23 | 01/08/24 | 31/07/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 25.66x | 6.82x | 17.52x | 0.9% | 3.96TCr | ||
| 30.39x | 5.25x | 20.75x | 0.31% | 20TCr | ||
| 55.25x | 14.3x | 33.4x | -.--% | 17TCr | ||
| 41.55x | 6.79x | 22.01x | 0.58% | 15TCr | ||
| 37.41x | 6.07x | 19.81x | -.--% | 11TCr | ||
| 20.46x | 2.36x | 11.61x | 2.56% | 5.46TCr | ||
| 34.77x | 6.99x | 23.13x | -.--% | 4.57TCr | ||
| 16.94x | 1.9x | 10.28x | 0.19% | 3.68TCr | ||
| 24.3x | 5.1x | 17.76x | 0.79% | 3.67TCr | ||
| 23.93x | 6.12x | 17.36x | 2.76% | 3.3TCr | ||
| Average | 31.07x | 6.17x | 19.36x | 0.81% | 8.9TCr | |
| Weighted average by Cap. | 36.41x | 7.25x | 22.05x | 0.51% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- RMD Stock
- Valuation ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















